Abstract
Hormone therapies can have very dramatic effects upon hearing abilities, depending on the timing, duration, and nature of the hormones. Overall, estrogen tends to be beneficial to hearing, consistent with its generally neuroprotective and neuromodulatory actions for neural and sensory systems. Indeed, menopausal women tend to benefit from estrogen hormone replacement therapy (HRT) in terms of hearing, but other serious side effects, including ovarian, uterine, and breast cancer risks, have to be taken into account carefully. The most common form of HRT prescribed clinically, so called “combination” HRT, consists of estrogen combined with progestin/progesterone. The largest clinical research study to date on its actions in post-menopausal women revealed decreases in auditory sensitivity (audiogram thresholds), declines in otoacoustic emission levels, and worse performance on hearing-in-background noise tests relative to controls (women who had never taken HRT). Other hormones, such as aldosterone, may be beneficial to hearing in older individuals who have reduced serum levels of this mineralocorticoid hormone. Thyroxine, given to patients suffering from hypothyroidism, also may be beneficial to hearing. And finally, examination of a series of otoacoustic emissions and evoked potential studies in different gender groups suggests that pre- or post-natal exposures to higher levels of testosterone correlate with declines in auditory processing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Borkholder, D. A., Zhu, X., & Frisina, R. D. (2014). Round window membrane intracochlear drug delivery enhanced by induced advection. Journal of Controlled Release, 174, 171–176.
Borkholder, D. A., Zhu, X., Hyatt, B. T., Archilla, A. S., Livingston, W. J., & Frisina, R. D. (2010). Murine intracochlear drug delivery: Reducing concentration gradients within the cochlea. Hearing Research, 268, 2–11.
Caras, M. L. (2013). Estrogenic modulation of auditory processing: A vertebrate comparison. Frontiers of Neuroendocrinology, 34, 285–299.
Caruso, S., Maiolino, L., Agnello, C., Garozzo, A., Di Mari, L., & Serra, A. (2003a). Effects of patch or gel estrogen therapies on auditory brainstem response in surgically postmenopausal women: A prospective, randomized study. Fertility Sterility, 79, 556–561.
Caruso, S., Maiolino, L., Rugolo, S., Intelisano, G., Farina, M., et al. (2003b). Auditory brainstem response in premenopausal women taking oral contraceptives. Human Reproduction, 18, 85–89.
Charitidi, K., & Canlon, B. (2009). Estrogen receptors in the central auditory system of male and female mice. Neuroscience, 165, 923–933.
Charitidi, K., Frisina, R. D., Vasilyeva, O. N., Zhu, X., & Canlon, B. (2010). Expression patterns of estrogen receptors in the central auditory system change in prepubertal and aged mice. Neuroscience, 170, 1270–1281.
Charitidi, K., Meltser, I., Tahera, Y., & Canlon, B. (2009). Functional responses of estrogen receptors in the male and female auditory system. Hearing Research, 252, 71–78.
Coleman, J. R., Campbell, D., Cooper, W. A., Welsh, M. G., & Moyer, J. (1994). Auditory brainstem responses after ovariectomy and estrogen replacement in rat. Hearing Research, 80, 209–215.
Craft, R. M., Mogil, J. S., & Aloisi, A. M. (2004). Sex differences in pain and analgesia: The role of gonadal hormones. European Journal of Pain, 8, 397–411.
Ding, B., Frisina, R. D., Zhu, X., Sakai, Y., Sokolowski, B., & Walton, J. P. (2014). Direct control of Na+-K+-2Cl– co-transport protein (NKCC1) expression with aldosterone. American Journal of Physiology - Cell Physiology, 306, C66–C75.
Feng, Y., Weijdegard, B., Wang, T., Egecioglu, E., Fernandez-Rodriguez, J., Huhtaniemi, I., et al. (2010). Spatiotemporal expression of androgen receptors in the female rat brain during the oestrous cycle and the impact of exogenous androgen administration: A comparison with gonadally intact males. Molecular and Cellular Endocrinology, 321, 161–174.
Gillies, G. E., & McArthur, S. (2010). Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson’s disease: A contribution to sex-specific neuroprotection by estrogens. Hormones and Behavior, 57, 23–34.
Goldey, E. S., & Crofton, K. M. (1998). Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicological Sciences, 45, 94–105.
Guimaraes, P., Frisina, S. T., Mapes, F., Tadros, S. F., Frisina, D. R., & Frisina, R. D. (2006). Progestin negatively affects hearing in aged women. Proceedings of the National Academy of Sciences of the USA, 103, 14246–14249.
Guimaraes, P., Zhu, X., Cannon, T., Kim, S., & Frisina, R. D. (2004). Sex differences in distortion product otoacoustic emissions as a function of age in CBA mice. Hearing Research, 192, 83–89.
Haggard, M., & Gaston, J. B. (1978). Changes in auditory perception in the menstrual cycle. British Journal of Audiology, 12(4), 105–118.
Haghpanahia, M., Gladstone, M. B., Zhu, X., Frisina, R. D., & Borkholder, D. A. (2013). Noninvasive quantification of transport through the murine cochlea using micro-computed tomography. Annals of Biomedical Engineering, 41, 2130–2142.
Hederstierna, C., Hultcrantz, M., & Rosenhall, U. (2009). A longitudinal study of hearing decline in women with Turner syndrome. Acta Oto-Laryngologica, 129(12), 1434–1441.
Hederstierna, C., Hultcrantz, M., & Rosenhall, U. (2010a). Estrogen and hearing from a clinical point of view; characteristics of auditory function in women with Turner syndrome. Hearing Research, 252(1–2), 3–8.
Hederstierna, C., Hultcrantz, M., Collins, A., & Rosenhall, U. (2010b). The menopause triggers hearing decline in healthy women. Hearing Research, 259, 31–35.
Helfer, K. (2004). Estrogen therapy affects speech processing in women. Experimental Aging Research, 30, 195–204.
Hultcrantz, M., Simonoska, R., & Stenberg, A. E. (2006). Estrogen and hearing: A summary of recent investigations. Acta Oto-Laryngologica, 126, 10–14.
Jerger, J., & Johnson, K. (1988). Interactions of age, gender, and sensorineural hearing loss on ABR latency. Ear and Hearing, 9, 168–175.
Johnson, D. G., Frisina, R. D., & Borkholder, D. A. (2011). In-plane biocompatible microfluidic interconnects for implantable microsystems. IEEE Transactions in Biomedical Engineering, 58, 943–948.
Johnson, D. G., Waldron, M. J., Frisina, R. D., & Borkholder, D. A. (2010). Implantable micropump technologies for murine intracochlear infusions. IEEE Engineering in Medicine and Biology Society, Conference Proceedings, 2010, 6441–6444.
Kilicdag, E. B., Yavuz, H., Bagis, T., Tarim, E., Nabi Erkan, A., & Kazanci, F. (2004). Effects of estrogen therapy on hearing in postmenopausal women. American Journal of Obstetrics & Gynecology, 190, 77–82.
King, K. A., Makishima, T., Zalewski, C. K., Bakalov, V. K., Griffith, A. J., Bondy, C. A., et al. (2007). Analysis of auditory phenotype and karyotype in 200 females with Turner syndrome. Ear and Hearing, 28(6), 831–841.
Knipper, M., Zinn, C., Maier, H., Praetorius, M., & Rohbock, K. (2000). Thyroid hormone deficiency before the onset of hearing causes irreversible damage to peripheral and central auditory systems. Journal of Neurophysiology, 83, 3101–3112.
Lautermann, J., & ten Cate, W. J. F. (1997). Postnatal expression of the α-thyroid hormone receptor in the rat cochlea. Hearing Research, 107, 23–28.
Loehlin, J. C., & McFadden, D. (2003). Otoacoustic emissions, auditory evoked potentials, and traits related to sex and sexual orientation. Archives of Sexual Behavior, 32(2), 115–127.
Maney, D., & Pinaud, R. (2011). Estradiol-dependent modulation of auditory processing and selectivity in songbirds. Frontiers of Neuroendocrinology, 32, 287–302.
McCarthy, K., & Bondy, C. A. (2008). Turner syndrome in childhood and adolescence. Expert Review of Endocrinology & Metabolism, 3(6), 771–775.
McCullar, J. S., & Oesterle, E. C. (2009). Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia. Hearing Research, 252, 61–70.
McFadden, D. (2000). Masculinizing effects on otoacoustic emissions and auditory evoked potentials in women using oral contraceptives. Hearing Research, 142, 23–33.
McFadden, D. (2002). Masculinization effects in the auditory system. Archives of Sexual Behavior, 31, 93–105.
McFadden, D. (2011). Sexual orientation and the auditory system. Frontiers of Neuroendocrinology, 32(2), 201–213.
McFadden, D., & Champlin, C. A. (2000). Comparison of auditory evoked potentials in heterosexual, homosexual, and bisexual males and females. Journal of the Association for Research in Otolaryngology, 1(1), 89–99.
McFadden, D., & Pasanen, E. G. (1998). Comparison of the auditory systems of heterosexuals and homosexuals: Click-evoked otoacoustic emissions. Proceedings of the National Academy of Sciences of the USA, 95, 2709–2713.
McFadden, D., & Pasanen, E. G. (1999). Spontaneous otoacoustic emissions in heterosexuals, homosexuals, and bisexuals. Journal of the Acoustical Society of America, 105(4), 2403–2413.
Meltser, I., Tahera, Y., Simpson, E., Hultcrantz, M., Charitidi, K., Gustafsson, J. A., et al. (2008). Estrogen receptor beta protects against acoustic trauma in mice. Journal of Clinical Investigation, 118, 1563–1570.
Nolan, L. S., Maier, H., Hermans-Borgmeyer, I., Girotto, G., Ecob, R., Pirastu, N., et al. (2013). Estrogen-related receptor gamma and hearing function: Evidence of a role in humans and mice. Neurobiology of Aging, 34(8), 2077.e1–2077.e9.
Parving, A. (1995). Factors causing hearing impairment: Some perspectives from Europe. Journal of the American Academy of Audiology, 6, 387–395.
Price, K., Zhu, X., Guimaraes, P., Vasilyeva, O. N., & Frisina, R. D. (2009). Hormone replacement therapy diminishes hearing in perimenopausal mice. Hearing Research, 252, 29–36.
Schmiedt, R. A. (1996). Effects of aging on potassium homeostasis and the endocochlear potential in the gerbil cochlea. Hearing Research, 102(1–2), 125–132.
Schmiedt, R. A. (2010). The physiology of cochlear presbycusis. In S. Gordon-Salant, R. D. Frisina, A. N. Popper, & R. R. Fay (Eds.), The aging auditory system: Perceptual characterization and neural bases of presbycusis (pp. 9–38). New York: Springer.
Simonoska, R., Stenberg, A. E., Duan, M., Yakimchuk, K., Fridberger, A., Sahlin, L., et al. (2009). Inner ear pathology and loss of hearing in estrogen receptor-beta deficient mice. Journal of Endocrinology, 201(3), 397–406.
Tadros, S. F., Frisina, S. T., Mapes, F., Frisina, D. R., & Frisina, R. D. (2005). High serum aldosterone levels correlate with lower hearing thresholds in aged humans: A possible protective hormone against presbycusis. Hearing Research, 209, 10–18.
Thompson, S. K., Zhu, X., & Frisina, R. D. (2006). Estrogen blockade reduces auditory feedback in CBA mice. Otolaryngology-Head and Neck Surgery, 135, 100–105.
Tremere, L. A., Jeong, J. K., & Pinaud, R. (2009). Estradiol shapes auditory processing in the adult brain by regulating inhibitory transmission and plasticity-associated gene expression. Journal of Neuroscience, 29(18), 5949–5963.
Trune, D. R., & Canlon, B. (2012). Corticosteroid therapy for hearing and balance disorders. Anatomical Record, 295(11), 1928–1943.
Trune, D. R., & Kempton, J. B. (2001). Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice. Hearing Research, 155(1–2), 9–20.
Trune, D. R., Kempton, J. B., & Gross, N. D. (2006). Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hearing Research, 212(1–2), 22–32.
Trune, D. R., Kempton, J. B., & Kessi, M. (2000). Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice. Laryngoscope, 110(11), 1902–1906.
Women’s Health Initiative. 2015. The estrogen-plus-progestin study (Website Report). Retrieved June 19, 2015, from https://www.nhlbi.nih.gov/whi/estro_pro.htm
Yoder, K. M., & Vicario, D. S. (2012). Modulate and be modulated: Estrogenic influences on auditory processing of communication signals within a socio-neuro-endocrine framework. Behavioral Neuroscience, 126, 17–28.
Zhu, X., Ding, B., Walton, J. P., & Frisina, R. D. (2014). Aldosterone reduces spiral ganglion neuron loss in middle age CBA/CaJ mice. Association for Research in Otolaryngology Abstracts, 37, 7.
Acknowledgments
This work was supported by NIH Grant P01 AG009524 from the National Institute on Aging, and R01 DC014568 from the National Institute on Deafness and Communication Disorders. We thank Shannon Salvog for assistance in project support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Frisina, R.D., Frisina, D.R. (2016). Hormone Replacement Therapy and Its Effects on Human Hearing. In: Bass, A., Sisneros, J., Popper, A., Fay, R. (eds) Hearing and Hormones. Springer Handbook of Auditory Research, vol 57. Springer, Cham. https://doi.org/10.1007/978-3-319-26597-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-26597-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26595-7
Online ISBN: 978-3-319-26597-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)